Chronic Wound Care Market Global Expansion Opportunities and Growth Forecast 2034

The global chronic wound care market cagr in 2026 is witnessing steady expansion as the prevalence of hard-to-heal wounds increases and healthcare providers adopt advanced wound management products. According to Fortune Business Insights, the global chronic wound care market size was valued at USD 15.27 billion in 2025 and is projected to grow from USD 16.39 billion in 2026 to USD 29.22 billion by 2034, exhibiting a CAGR of 7.50% during the forecast period. North America dominated the chronic wound care market with a market share of 37.42% in 2025.

Chronic wounds are difficult to heal and may involve prolonged tissue or skin damage. The major categories include diabetic ulcers, pressure ulcers, venous leg ulcers, and arterial ulcers. The increasing prevalence of these conditions is generating demand for wound dressings, wound care devices, active therapies, and other treatment solutions. The growing need for effective wound management is also encouraging companies to develop advanced products and technologies for chronic wound treatment.

Top Companies In The Market

Smith & Nephew, Mölnlycke Health Care AB, 3M, ConvaTec Group PLC, Tissue Regenix, B. Braun Melsungen AG, Integra LifeSciences Corporation, Coloplast Corp, Cardinal Health, and MiMedx are among the key companies profiled in the chronic wound care market.

Market Drivers & Restraints

The increasing prevalence of chronic wounds is a major factor supporting market growth. Rising cases of diabetic ulcers, pressure ulcers, and other chronic wounds are increasing the need for advanced dressings, devices, and active therapies. Pressure ulcers are also identified as an important cause of chronic wounds, while the increasing incidence of diabetic foot ulcers is contributing to demand for effective wound management solutions.

Technological advancements in wound treatment are another important growth factor. Market players are focusing on innovative products, including advanced dressings, foam dressings, bioactive therapies, and other wound healing solutions. The increasing application of active therapies is supporting adoption, particularly for difficult-to-heal wounds. Artificial intelligence is also being integrated into chronic wound management. AI-enabled solutions can use sensors and patient information such as weight, height, and body position to support pressure-ulcer prevention.

However, the high cost of treatment and inadequate reimbursement policies in emerging countries can restrict product adoption. Advanced wound dressings, wound care devices, and bioactive products can involve significant treatment costs. Limited reimbursement for these products can create challenges for patients and healthcare systems, particularly in emerging markets.

Market Competitive Landscape

The market structure is consolidated, with leading companies maintaining strong positions through extensive product portfolios and broad distribution networks. Smith & Nephew, ConvaTec, and 3M are among the major players highlighted in the report. Companies are emphasizing new product launches, strategic expansion, and acquisitions to strengthen their market presence.

Recent industry developments include ConvaTec Group PLC launching ConvaFoam in the U.S. in January 2023. The product is a super absorber foam dressing designed for highly exuding wounds, including venous leg ulcers, pressure ulcers, and diabetic foot ulcers. In January 2021, Integra LifeSciences Corporation announced the acquisition of ACell, Inc. to provide more comprehensive complex wound management solutions.

Other developments include JeNaCell, an Evonik company, introducing epicite balance for chronic wounds in Germany in June 2023. MiMedx entered into an exclusive distribution agreement with Gunze Medical Limited in January 2023 for Epifix in Japan. ConvaTec Group PLC also acquired Triad Life Sciences in March 2022 to enter the wound biologics segment and expand its advanced wound care portfolio.

Market Segments

By Type (Diabetic Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others)

By Product (Advanced Wound Dressings, Wound Care Devices, Active Therapy, and Others)

By End-User (Hospitals & Wound Care Centers and Homecare Settings & Others)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/chronic-wound-care-market-100222 

Market Regional Insights

North America dominated the global chronic wound care market in 2025, generating USD 5.69 billion and accounting for 37.42% of global market revenue. The regional market is projected to reach USD 6.09 billion in 2026. The region's position is supported by the prevalence of chronic wounds, treatment expenditure, and reimbursement policies in the U.S. and Canada. The U.S. market is projected to reach USD 5.44 billion in 2026.

Europe generated USD 5.14 billion in 2025, representing 33.44% of global market revenue, and is expected to reach USD 5.52 billion in 2026. The growth is associated with the increasing chronic wound patient population and expenditure on treatment for diabetic ulcers, pressure ulcers, and venous ulcers.

Asia Pacific generated USD 3.41 billion in 2025, capturing 22.32% of the global market. Increasing awareness of treatment options and rising healthcare spending are supporting market development in the region. The Japan market is projected to reach USD 0.87 billion, China USD 1.83 billion, and India USD 0.32 billion in 2026.

Latin America and the Middle East & Africa accounted for comparatively lower market shares due to limited awareness, lower per capita income, and inadequate reimbursement policies. The Middle East & Africa market generated USD 0.45 billion in 2025, while Latin America generated USD 0.58 billion in 2025.

Future Market Scope

The future growth of the chronic wound care market is expected to be supported by the rising prevalence of chronic wounds, technological advancements, new product launches, and increasing adoption of active therapies. Advanced wound dressings, wound care devices, and active therapies are expected to remain important areas of market development. The integration of artificial intelligence into wound management may further support preventive and personalized approaches to chronic wound care.

As healthcare providers continue to address hard-to-heal wounds, companies are expected to focus on innovative treatment solutions and expanded product portfolios. Strategic acquisitions, collaborations, distribution agreements, and new product introductions are also expected to influence the competitive landscape.

What Everyone Should Know About Japan’s Market -Chronic Wound Care Market- Insights